Close

Ratings by B.Riley (Justin Walsh)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/18/2024 Lantheus Holdings LNTH Maintain Buy
(N/A)
 
 
  Details
12/20/2023 Checkpoint Therapeutics CKPT Maintain Buy
(N/A)
 
 
  Details
12/19/2022 Checkpoint Therapeutics CKPT Maintain Buy
(N/A)
 
 
  Details
8/25/2022 Lantheus Holdings LNTH Maintain Buy
(N/A)
 
 
  Details
7/14/2022 Checkpoint Therapeutics CKPT New Coverage Buy
(N/A)
1.08
(1.88)
74.07% Details
5/19/2022 Harrow Health HROW Maintain Buy
(N/A)
 
 
  Details
5/9/2022 Lantheus Holdings LNTH New Coverage Buy
(N/A)
64.15
(79.67)
24.19% Details
5/4/2022 CytoSorbents CTSO Maintain Buy
(N/A)
 
 
  Details
3/9/2022 CytoSorbents CTSO Maintain Buy
(N/A)
 
 
  Details
1/19/2022 Compass Therapeutics CMPX New Coverage Buy
(N/A)
2.76
(1.60)
-42.03% Details
1/11/2022 ViewRay Inc. VRAY Upgrade Buy
(Neutral)
4.96
(4.51)
-9.07% Details
10/14/2021 CytoSorbents CTSO New Coverage Buy
(N/A)
6.13
(0.97)
-84.18% Details
10/14/2021 Harrow Health HROW New Coverage Buy
(N/A)
10.19
(16.76)
64.47% Details
10/14/2021 Eton Pharmaceuticals ETON New Coverage Buy
(N/A)
5.43
(3.62)
-33.33% Details
10/14/2021 ViewRay Inc. VRAY New Coverage Buy
(N/A)
6.41
(0.03)
-99.53% Details
9/2/2021 Portage Biotech inc. PRTG New Coverage Buy
(N/A)
21.61
(0.26)
-98.8% Details
8/26/2021 Fusion Pharmaceuticals FUSN New Coverage Buy
(N/A)
8.31
(21.51)
158.84% Details
6/9/2021 F-Star Therapeutics Inc. FSTX New Coverage Buy
(N/A)
6.95
(7.12)
2.45% Details
6/9/2021 Checkpoint Therapeutics CKPT New Coverage Buy
(N/A)
2.66
(1.88)
-29.32% Details
2/18/2021 Syndax Pharmaceuticals SNDX New Coverage Buy
(N/A)
21.26
(20.29)
-4.56% Details
2/18/2021 Precigen Inc. PGEN New Coverage Buy
(N/A)
8.07
(1.38)
-82.9% Details